RecallHawk

CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE

SUN PHARM INDS LTD

Summary

FDA approved CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE by SUN PHARM INDS LTD. ANDA (Generic) approval (Labeling) on 2025-05-20. TABLET, EXTENDED RELEASE, ORAL.

Details

Source

Drug Approval

External ID

ANDA090922-16

Action Date

2025-05-20

Status

Approved

Category

drug

Product Code

ANDA (Generic)

Product Description

CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, TABLET, EXTENDED RELEASE, ORAL. Application: ANDA090922

Context & Analysis

SUN PHARM INDS LTD has 10 FDA actions in our database.

Frequently Asked Questions

How often does SUN PHARM INDS LTD have FDA actions?

SUN PHARM INDS LTD has 10 FDA actions in our database, including 0 recalls and 0 device clearances.

Where can I find the official FDA record?

The official record is available on FDA.gov. Search for "ANDA090922-16" on FDA.gov for the full record. You can also use the openFDA API to query this record programmatically.

Want to know the moment something like this happens?

Get alerts for drug

Related Actions